Using antibodies P1G4 (IgG1) and P3A5 (IgG2a) that were generated against the AGR2 protein, a high expression of AGR2 was revealed in prostate tumor specimen tissues and cultured cells [53]. This evidence concerns the gene AGR2 and prostate neoplasm.